Steve Valiquette
Stock Analyst at Barclays
(1.92)
# 2,929
Out of 4,829 analysts
175
Total ratings
46.49%
Success rate
-3.58%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $7 → $7.5 | $6.84 | +9.65% | 4 | Apr 16, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $7.11 | +68.78% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $11.22 | -28.70% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $693.46 | -11.17% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.32 | +108.33% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $3.56 | +40.45% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $5.24 | +90.84% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $15.35 | +56.35% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $66.97 | +28.42% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $62.79 | +35.37% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $275 → $300 | $353.70 | -15.18% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $95.30 | -7.66% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $35.90 | -5.29% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $148.83 | -29.45% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $66.01 | -16.68% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $18.19 | -28.53% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $181.78 | -21.88% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $24.70 | -79.76% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $116.41 | -51.04% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $149.18 | -45.03% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $17.47 | +3.03% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $35.86 | -13.55% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $322.20 | +16.39% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $29.15 | -34.82% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $249.53 | +128.43% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $148.22 | -56.82% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $333.46 | -7.04% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $380.64 | +48.43% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $8.20 | +814.63% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $3.64 | +421.98% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.50 | +185.71% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $23.07 | +47.38% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $5.40 | +270.37% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $123.79 | +110.03% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Apr 16, 2025
Maintains: Equal-Weight
Price Target: $7 → $7.5
Current: $6.84
Upside: +9.65%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $7.11
Upside: +68.78%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $11.22
Upside: -28.70%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $693.46
Upside: -11.17%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.32
Upside: +108.33%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $3.56
Upside: +40.45%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $5.24
Upside: +90.84%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $15.35
Upside: +56.35%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $66.97
Upside: +28.42%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $62.79
Upside: +35.37%
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $353.70
Upside: -15.18%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $95.30
Upside: -7.66%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $35.90
Upside: -5.29%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $148.83
Upside: -29.45%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $66.01
Upside: -16.68%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $18.19
Upside: -28.53%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $181.78
Upside: -21.88%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $24.70
Upside: -79.76%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $116.41
Upside: -51.04%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $149.18
Upside: -45.03%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $17.47
Upside: +3.03%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $35.86
Upside: -13.55%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $322.20
Upside: +16.39%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $29.15
Upside: -34.82%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $249.53
Upside: +128.43%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $148.22
Upside: -56.82%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $333.46
Upside: -7.04%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $380.64
Upside: +48.43%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $8.20
Upside: +814.63%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $3.64
Upside: +421.98%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.50
Upside: +185.71%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $23.07
Upside: +47.38%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $5.40
Upside: +270.37%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $123.79
Upside: +110.03%